Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 984 products on this category.

Product data	Purity	Price range	Estimated delivery
(E)-4-Hydroxy Tamoxifen REF: 4Z-T-0140CAS: 174592-47-3	- - -	To inquire	Thu 19 Dec 24
3-Hydroxy Tamoxifen REF: 4Z-T-0139CAS: 82413-20-5	- - -	To inquire	Thu 19 Dec 24
Olaparib Impurity 3 REF: 4Z-O-032005CAS: 61260-15-9	- - -	To inquire	Thu 19 Dec 24
Carfilzomib Impurity 32 REF: 4Z-C-121035	- - -	To inquire	Thu 19 Dec 24
Enzalutamide Impurity 4 REF: 4Z-E-068015	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 78 REF: 4Z-N-066089CAS: 100-23-2	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 87 REF: 4Z-N-066100	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 95 REF: 4Z-N-066108	- - -	To inquire	Thu 19 Dec 24
Palbociclib Impurity 65 REF: 4Z-P-196072	- - -	To inquire	Thu 19 Dec 24
Palbociclib Impurity 33 REF: 4Z-P-196038CAS: 2363160-84-1	- - -	To inquire	Thu 19 Dec 24
Enzalutamide Impurity 53 REF: 4Z-E-068066CAS: 948294-47-1	- - -	To inquire	Thu 19 Dec 24
Cyclopropanecarbonyl Chloride REF: 4Z-O-032037CAS: 4023-34-1	- - -	To inquire	Thu 19 Dec 24
Olaparib Impurity 67 REF: 4Z-O-032072CAS: 1245915-98-3	- - -	To inquire	Thu 19 Dec 24
Olaparib Impurity 63 REF: 4Z-O-032068CAS: 40019-44-1	- - -	To inquire	Thu 19 Dec 24
Tamoxifen Impurity 1 REF: 4Z-T-0120CAS: 76117-70-9	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 49 REF: 4Z-N-066067CAS: 380427-39-4	- - -	To inquire	Thu 19 Dec 24
Fulvestrant Impurity 4 REF: 4Z-F-3117CAS: 1621885-82-2	- - -	To inquire	Thu 19 Dec 24
Bestatin Impurity 29 REF: 4Z-B-119035	- - -	To inquire	Thu 19 Dec 24
Nintedanib Impurity 63 REF: 4Z-N-066081CAS: 2243384-71-4	- - -	To inquire	Thu 19 Dec 24
Lenvatinib Impurity 40 REF: 4Z-L-124046	- - -	To inquire	Thu 19 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

(E)-4-Hydroxy Tamoxifen

Ref: 4Z-T-0140

3-Hydroxy Tamoxifen

Ref: 4Z-T-0139

Olaparib Impurity 3

Ref: 4Z-O-032005

Carfilzomib Impurity 32

Ref: 4Z-C-121035

Enzalutamide Impurity 4

Ref: 4Z-E-068015

Nintedanib Impurity 78

Ref: 4Z-N-066089

Nintedanib Impurity 87

Ref: 4Z-N-066100

Nintedanib Impurity 95

Ref: 4Z-N-066108

Palbociclib Impurity 65

Ref: 4Z-P-196072

Palbociclib Impurity 33

Ref: 4Z-P-196038

Enzalutamide Impurity 53

Ref: 4Z-E-068066

Cyclopropanecarbonyl Chloride

Ref: 4Z-O-032037

Olaparib Impurity 67

Ref: 4Z-O-032072

Olaparib Impurity 63

Ref: 4Z-O-032068

Tamoxifen Impurity 1

Ref: 4Z-T-0120

Nintedanib Impurity 49

Ref: 4Z-N-066067

Fulvestrant Impurity 4

Ref: 4Z-F-3117

Bestatin Impurity 29

Ref: 4Z-B-119035

Nintedanib Impurity 63

Ref: 4Z-N-066081

Lenvatinib Impurity 40

Ref: 4Z-L-124046